Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Promethera Biosciences
Promethera Biosciences
Activities:
Research & Development
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Pharmaceutical
Promethera Biosciences expands executive management team and appoints new Chairman
Torsten Hombeck becomes Chief Commercial and Strategy Officer and Christof Hettich takes over as Chairman
Research & Development
Belgian biotech Promethera makes two senior appointments
Dr Jürgen Beck is hired as VP Clinical and Medical Affairs, with Patrick Stragier as VP Operations
Research & Development
Promethera Biosciences sees departure of CEO Eric Halioua
The recruitment process to find his successor is underway
Pharmaceutical
Dr John Tchelingerian becomes Chairman of Promethera Biosciences
Biotech entrepreneur brings scientific, dealmaking and commercial experience to the team
Research & Development
EMD Millipore to collaborate with Promethera Biosciences
Promethera to use microfluidic system from Millipore for liver disease research
Subscribe now